Teppei Sugano1,2, Mari Masuda1, Fumitaka Takeshita3, Noriko Motoi4, Toru Hirozane5, Naoko Goto1, Shigeki Kashimoto6, Yuko Uno6, Hideki Moriyama6, Masaaki Sawa6, Yuichi Nagakawa7, Akihiko Tsuchida7, Masahiro Seike2, Akihiko Gemma2, Tesshi Yamada8,9. 1. Division of Chemotherapy and Clinical Research, National Cancer Center Research Institute, Tokyo, 104-0045, Japan. 2. Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, 113-8602, Japan. 3. Department of Functional Analysis, Fundamental Innovative Oncology Core Center (FIOC), National Cancer Center Research Institute, Tokyo, 104-0045, Japan. 4. Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, 104-0045, Japan. 5. Department of Orthopedic Surgery, Keio University School of Medicine, Tokyo, 160-8582, Japan. 6. Carna Biosciences, Inc, Kobe, 650-0047, Japan. 7. Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Tokyo, 160-0023, Japan. 8. Division of Chemotherapy and Clinical Research, National Cancer Center Research Institute, Tokyo, 104-0045, Japan. tesshi.yamada@gmail.com. 9. Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Tokyo, 160-0023, Japan. tesshi.yamada@gmail.com.
Abstract
BACKGROUND: Metastasis is the primary cause of death in cancer patients, and its management is still a major challenge. Epithelial to mesenchymal transition (EMT) has been implicated in the process of cancer metastasis, and its pharmacological interference holds therapeutic promise. METHODS: Traf2- and Nck-interacting kinase (TNIK) functions as a transcriptional coregulator of Wnt target genes. Given the convergence of Wnt and transforming growth factor-β (TGFβ) signalling, we examined the effects of a small-molecule TNIK inhibitor (named NCB-0846) on the TGFβ1-induced EMT of lung cancer cells. RESULTS: NCB-0846 inhibited the TGFβ1-induced EMT of A549 cells. This inhibition was associated with inhibition of Sma- and Mad-Related Protein-2/3 (SMAD2/3) phosphorylation and nuclear translocation. NCB-0846 abolished the lung metastasis of TGFβ1-treated A549 cells injected into the tail veins of immunodeficient mice. The inhibition of EMT was mediated by suppression of the TGFβ receptor type-I (TGFBR1) gene, at least partly through the induction of microRNAs targeting the TGFBR1 transcript [miR-320 (a, b and d) and miR-186]. CONCLUSIONS: NCB-0846 pharmacologically blocks the TGFβ/SMAD signalling and EMT induction of lung cancer cells by transcriptionally downregulating TGFBRI expression, representing a potentially promising approach for prevention of metastasis in lung cancer patients.
BACKGROUND: Metastasis is the primary cause of death in cancerpatients, and its management is still a major challenge. Epithelial to mesenchymal transition (EMT) has been implicated in the process of cancer metastasis, and its pharmacological interference holds therapeutic promise. METHODS:Traf2- and Nck-interacting kinase (TNIK) functions as a transcriptional coregulator of Wnt target genes. Given the convergence of Wnt and transforming growth factor-β (TGFβ) signalling, we examined the effects of a small-molecule TNIK inhibitor (named NCB-0846) on the TGFβ1-induced EMT of lung cancer cells. RESULTS:NCB-0846 inhibited the TGFβ1-induced EMT of A549 cells. This inhibition was associated with inhibition of Sma- and Mad-Related Protein-2/3 (SMAD2/3) phosphorylation and nuclear translocation. NCB-0846 abolished the lung metastasis of TGFβ1-treated A549 cells injected into the tail veins of immunodeficientmice. The inhibition of EMT was mediated by suppression of the TGFβ receptor type-I (TGFBR1) gene, at least partly through the induction of microRNAs targeting the TGFBR1 transcript [miR-320 (a, b and d) and miR-186]. CONCLUSIONS:NCB-0846 pharmacologically blocks the TGFβ/SMAD signalling and EMT induction of lung cancer cells by transcriptionally downregulating TGFBRI expression, representing a potentially promising approach for prevention of metastasis in lung cancerpatients.
Authors: Martin Larhammar; Sarah Huntwork-Rodriguez; York Rudhard; Arundhati Sengupta-Ghosh; Joseph W Lewcock Journal: J Neurosci Date: 2017-10-09 Impact factor: 6.167
Authors: Daniël P de Bruyn; Aaron B Beasley; Robert M Verdijk; Natasha M van Poppelen; Dion Paridaens; Ronald O B de Keizer; Nicole C Naus; Elin S Gray; Annelies de Klein; Erwin Brosens; Emine Kiliç Journal: Biomedicines Date: 2022-02-21
Authors: Luo Chen; Yiu Chun Chiang; Lai Sheung Chan; Wai Yin Chau; Maria Li Lung; Michael Kahn; Kwok Wai Lo; Nai Ki Mak; Hong Lok Lung Journal: Cancers (Basel) Date: 2022-06-25 Impact factor: 6.575